Pulmonx (LUNG) Cash & Equivalents Growth (1y) (2020 - 2025)
Powered by 
Analysis
Pulmonx (LUNG) Cash & Equivalents Growth (1y) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.08 Bn | 174.48 Bn | 7.27 Bn | -26.57% |
| 2 | Intuitive Surgical | 127.86 Bn | 122.64 Bn | 1.96 Bn | -19.91% |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | 32.84% |
| 4 | Stryker | 103.82 Bn | 100.34 Bn | 4.50 Bn | 42.78% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 0.94% |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn | -11.19% |
| 7 | Alcon | 32.95 Bn | 31.49 Bn | 1.68 Bn | -3.76% |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | -4.66% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 72.43% |
| 10 | Pulmonx | 76.96 Mn | 7.21 Mn | - | -1.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.63% |
| Sep 30, 2025 | 20.91% |
| Jun 30, 2025 | 18.91% |
| Mar 31, 2025 | 6.27% |
| Dec 31, 2024 | -15.13% |
| Sep 30, 2024 | -33.32% |
| Jun 30, 2024 | -37.52% |
| Mar 31, 2024 | -36.46% |
| Dec 31, 2023 | -17.88% |
| Sep 30, 2023 | -15.53% |
| Jun 30, 2023 | -16.70% |
| Mar 31, 2023 | -14.52% |
| Dec 31, 2022 | -31.48% |
| Sep 30, 2022 | -40.24% |
| Jun 30, 2022 | -38.63% |
| Mar 31, 2022 | -38.28% |
| Dec 31, 2021 | -35.88% |
| Sep 30, 2021 | 372.48% |
| Jun 30, 2021 | 358.40% |
| Mar 31, 2021 | 1,188.61% |